20672 ⎘
Medicinal preparations containing materials or reaction products thereof with undetermined constitution; Microorganisms or materials therefrom; Viruses; Subviral particles; Bacteriophages Adenovirus
Oncolytic virus replicating selectively in tumor cells
#602Use of adenovirus and nucleic acids coding therefor
#603Simian adenoviruses SAdV-36, -42.1, -42.2, and -44 and uses thereof
#604NOVEL USE OF ADENOVIRUSES AND NUCLEIC ACIDS THAT CODE FOR SAID VIRUSES
#605Methods for Reversing Multiple Resistance in Animal Cells
#606THERAPEUTIC REGIMEN FOR TREATING CANCER
#607Simian subfamily B adenoviruses SAdV-28, -27, -29, -32, -33, and -35 and uses thereof
#608CHIMERIC ADENOVIRUS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL USING THE SAME
#609Decreasing cancer cell proliferation with WNT remaining active
#610Viruses for the treatment of cellular proliferative disorders
#611Myostatin inhibition for enhancing muscle and/or improving muscle function
#612TARGETED TUMOR THERAPY BY USE OF RECOMBINANT ADENOVIRUS VECTORS THAT SELECTIVELY REPLICATE IN HYPOXIC REGIONS OF TUMORS
#613Anticancer Agent to Be Combined with Telomelysin
#614ISOLATED DNA FRAGMENT OF THE HUMAN A33 PROMOTER AND ITS USE TO CONTROL THE EXPRESSION OF A HETEROLOGOUS GENE IN TUMOR CELLS
#615Methods of treating Parkinson's disease using viral vectors
#616Oncolytic Adenoviruses and Uses Thereof
#617METHOD FOR THE PRODUCTION AND PURIFICATION OF RETROVIRAL VECTORS
#618Replication-competent anti-cancer vectors
#619Oncolytic Adenoviruses for Cancer Treatment
#620Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
#621Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site
#622Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#623Chimeric adenoviruses for use in cancer treatment
#624Recombinant gene of adenovirus vector and p53 gene for treating proliferative diseases
#625ADENOVIRUSES MUTATED IN THE VA GENES FOR CANCER TREATMENT
#626PROLONGED DELIVERY OF HEPARIN-BINDING GROWTH FACTORS FROM HEPARIN-DERIVATIZED COLLAGEN
#627Oncolytic adenovirus armed with therapeutic genes
#628Multivalent vaccines comprising recombinant viral vectors
#629Tumor-targeting gene-virus zd55-il 24,its construction method and application thereof
#630Composition and method for killing of tumours
#631Uniform field magnetization and targeting of therapeutic formulations
#632Methods and reagents for the enhancement of virus transduction in the bladder epithelium
#633Viral vectors whose replication and, optionally, passenger gene are controlled by a gene switch activated by heat in the presence or absence of a small-molecule regulator
#634Oncolytic Adenovirus Armed with Therapeutic Genes
#635Methods of treating neoplasia with combination target cell-specific adenovirus, chemotherapy and radiation
#636Method and reagents for the enhancement of virus transduction in the bladder epithelium
#637Cancer-targeted viral vectors
#638Combined gene therapy for the treatment of macroscopic gliomas
#639Methods and reagents for the enhancement of virus transduction in the bladder epithelium
#640Oncolytic adenoviral vectors encoding GM-CSF
#641Methods and reagents for the enhancement of virus transduction in the bladder epithelium
#642Methods and reagents for the enhancement of virus transduction in the bladder epithelium
#643Liquid adenovirus formulations
#644HUMAN MATRIX METALLOPROTEINASE-8 GENE DELIVERY ENHANCES THE ONCOLYTIC ACTIVITY OF A REPLICATING ADENOVIRUS
#645METHODS AND COMPOSITIONS FOR GENE THERAPY
#646Formulation for adenovirus storage
#647Adenoviruses mutated in the VA genes for cancer treatment
#648Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#649Adeno-associated virus (AAV) serotype 8 sequences, vectors containing the same, and uses therefor
#650Method for the production and purification of adenoviral vectors
#651Viruses for the treatment of cellular proliferative disorders
#652Viruses for the treatment of cellular proliferative disorders
#653Viruses for the treatment of cellular proliferative disorders
#654Methods and Compositions for Viral Enhancement of Cell Killing
#655COMBINATION THERAPY WITH ONCOLYTIC ADENOVIRUS
#656RECOMBINANT ADENOVIRAL VECTORS AND METHODS OF USE
#657THERAPEUTIC REGIMEN FOR TREATING CANCER
#658Method for the production and purification of adenoviral vectors
#659Composition for the preservation of viruses
#660Cancer gene therapeutic drug
#661Cancer gene therapeutic drug
#662Adenoviral vectors having a protein IX deletion
#663Novel use of adenoviruses and nucleic acids that code for said viruses
#664Viruses for the treatment of cellular proliferative disorders
#665Method of preparing a proliferation-regulated recombinant adenoviral vector efficiently and kit for preparing the same
#666Recombinant adenoviral vector and method of use
#667Adenoviral vectors having a protein IX deletion
#668Nucleic acid delivery
#669Adenoviral vectors for treating diseases
#670Cell proliferation inhibitory proteins and polynucleotides, antisense polynucleotides to the polynucleotides, cell proliferation inhibitors using the foregoing, cancer diagnostic agents, cancer therapeutic agents and compositions for gene therapy
#671Adenoviral vectors for treating diseases
#672Adenoviral vectors for treating diseases
#673Use of adenoviruses mutated in the VA genes for cancer treatment
#674Human prolyl isomerase 1 (PIN 1) promoter and uses thereof
#675Composition and method for killing of tumours
#676Oncolytic adenovirus armed with therapeutic genes
#677Recombinant adenoviral vectors and methods of use
#678Targeted tumor therapy by use of recombinant adenovirus vectors that selectively replicate in hypoxic regions of tumors
#679Novel use of adenoviruses and nucleic acids coding therefor
#680Adenoviral vectors having a protein IX deletion
#681Adenoviral vectors having a protein IX deletion
#682Replication-competent anti-cancer vectors
#683Methods of treating neoplasia with combinations of target cell-specific adenovirus and chemotherapy
#684Target cell-specific adenoviral vectors containing E3 and methods of use thereof
#685Cancer - targeted viral vectors
#686Packaging cell line for diphtheria toxin expressing non-replicating adenovirus
#687Oncolytic adenoviral vectors encoding GM-CSF
#688Construct of tumor-selective recombinant adenovirus, method for preparing the same and use thereof
#689Chimeric adenoviruses for use in cancer treatment
#690Conditionally replicative adenovirus to target the Rb and Rb-related pathways
#691Compositions and methods for treating cancer with an oncolytic viral agent
#692Viruses with enhanced lytic potency
#693Oncolytic adenoviral vectors encoding GM-CSF
#694Methods of treating parkinson's disease using viral vectors
#695Formulation of adenovirus for gene therapy
#696Anti-neoplastic viral agents
#697Methods and compositions for viral enhancement of cell killing
#698Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site
#699Hepatocellular carcinoma specific promoter and uses thereof
#700Method for production of oncolytic adenoviruses
#701Modified adenovirus containing a fiber replacement protein
#702Method for the production and purification of adenoviral vectors
#703Construct of anti-cancer recombinant adenovirus, method for preparing the same and use thereof
#704Adenovirus E1B-55K single amino acid mutants and methods of use
#705Defective recombinant adenoviruses expressing cytokines for antitumor treatment
#706Subgroup B adenoviral vectors for treating disease
#707Composition for viral preservation
#708Tumor-specific promotor and use thereof
#709Nucleic acid delivery
#710Recombinantly-modified adeno-associated virus (rAAV) having improved packaging efficiency
#711TAA/ecdCD40L oncolytic virus